Skip to main content
Top

Open Access 29-01-2025 | Soft Tissue Sarcoma | ASO Author Reflections

ASO Author Reflections: Enhancing Shared Decision-Making with Risk Prediction Models in Sarcoma Care

Authors: Leti van Bodegom-Vos, PhD, Anouk Kruiswijk, MSc, Michiel van de Sande, MD, PhD

Published in: Annals of Surgical Oncology

Login to get access

Excerpt

Risk prediction models (RPMs) have become essential tools in modern oncology, supporting clinicians in making data-driven, personalized treatment decisions. These statistical tools predict individual patient outcomes on the basis of clinical characteristics, enhancing evidence-based medicine and shared decision-making. RPMs have found applications across various conditions, including breast cancer and currently in soft tissue sarcoma (STS) management. Tools such as Sarculator1 and PERSARC,2 designed specifically for STS, estimate risks of recurrence and survival using clinical parameters to tailor sarcoma treatment strategies. …
Literature
2.
go back to reference Rueten-Budde AJ, van de Sande MAJ, van Praag VM, et al. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma. J Surg Oncol. 2021;123(4):1050–6.CrossRefPubMed Rueten-Budde AJ, van de Sande MAJ, van Praag VM, et al. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma. J Surg Oncol. 2021;123(4):1050–6.CrossRefPubMed
3.
go back to reference Kruiswijk AA, Engelhardt EG, Vlug LAE, et al. VALUE-PERSARC research group. Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice—a mixed methods study. Eur J Cancer. 2024;210:114269.CrossRefPubMed Kruiswijk AA, Engelhardt EG, Vlug LAE, et al. VALUE-PERSARC research group. Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice—a mixed methods study. Eur J Cancer. 2024;210:114269.CrossRefPubMed
5.
go back to reference Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32(11):1348–65.CrossRefPubMed Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32(11):1348–65.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Enhancing Shared Decision-Making with Risk Prediction Models in Sarcoma Care
Authors
Leti van Bodegom-Vos, PhD
Anouk Kruiswijk, MSc
Michiel van de Sande, MD, PhD
Publication date
29-01-2025
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-025-16970-1
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now